DK124340B - Method for producing strong attenuated, live Newcastle disease virus vaccine. - Google Patents

Method for producing strong attenuated, live Newcastle disease virus vaccine.

Info

Publication number
DK124340B
DK124340B DK599270AA DK599270A DK124340B DK 124340 B DK124340 B DK 124340B DK 599270A A DK599270A A DK 599270AA DK 599270 A DK599270 A DK 599270A DK 124340 B DK124340 B DK 124340B
Authority
DK
Denmark
Prior art keywords
disease virus
virus vaccine
newcastle disease
producing strong
live newcastle
Prior art date
Application number
DK599270AA
Other languages
Danish (da)
Inventor
H Ito
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DK124340B publication Critical patent/DK124340B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK599270AA 1969-11-29 1970-11-25 Method for producing strong attenuated, live Newcastle disease virus vaccine. DK124340B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9581969 1969-11-29

Publications (1)

Publication Number Publication Date
DK124340B true DK124340B (en) 1972-10-09

Family

ID=14148007

Family Applications (1)

Application Number Title Priority Date Filing Date
DK599270AA DK124340B (en) 1969-11-29 1970-11-25 Method for producing strong attenuated, live Newcastle disease virus vaccine.

Country Status (7)

Country Link
CA (1) CA962593A (en)
DE (1) DE2058645C2 (en)
DK (1) DK124340B (en)
ES (1) ES385968A1 (en)
FR (1) FR2073436B1 (en)
GB (1) GB1274820A (en)
NL (1) NL170595C (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU826584A1 (en) * 1979-10-29 1982-11-07 Всесоюзный государственный научно-контрольный институт ветеринарных препаратов Vaccine against newcastle fowl disease, process for preparing the same and method for prophylaxis of newcastle fowl diease
HU197517B (en) * 1984-07-30 1989-04-28 Laszlo Csatary Process for production of terapeutical composition applicable against virus infection
US5124148A (en) * 1988-04-27 1992-06-23 United Cancer Research Institute Method for treating viral diseases with attenuated virus
ES2619936T3 (en) 2004-11-05 2017-06-27 Wellstat Biologics Corporation Stable and filterable enveloped virus formulations
CN102268410B (en) * 2011-06-17 2013-02-27 湖北省农业科学院畜牧兽医研究所 Newcastle disease virus heat-resistant attenuated strain adapted to baby hamster kidney passage cell and preparation method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2767117A (en) * 1953-10-22 1956-10-16 Crawley John Frederick Poultry virus vaccine products and method of preparing the same
GB1010509A (en) * 1962-02-23 1965-11-17 Pfizer Ltd Improvements in or relating to newcastle disease virus vaccines

Also Published As

Publication number Publication date
ES385968A1 (en) 1973-11-16
NL7017334A (en) 1971-06-02
GB1274820A (en) 1972-05-17
NL170595C (en) 1982-12-01
NL170595B (en) 1982-07-01
CA962593A (en) 1975-02-11
FR2073436A1 (en) 1971-10-01
FR2073436B1 (en) 1974-08-30
DE2058645A1 (en) 1971-06-09
DE2058645C2 (en) 1982-02-11

Similar Documents

Publication Publication Date Title
DK131776B (en) Process for the preparation of internal hemiacylals of cis-3,3-dimethyl-2-formylcyclopropane-1-carboxylic acid.
DK117316B (en) Method for producing mono- or polyfunctional vaccines against human, equine, porcine or avian influenza viruses.
DK108985C (en) Method for producing measles vaccine containing live, attenuated measles virus.
DK111568B (en) Process for the preparation of N-alkyl-3,1-benzoxazin-2-ones.
DK140697B (en) Process for the preparation of 2-amino-4-hydroxy-6-hydroxymethyl-7,7-dimethyl-7,8-dihydropteridine.
DK124340B (en) Method for producing strong attenuated, live Newcastle disease virus vaccine.
DK119627B (en) Method for purifying lipopolysaccharides.
CH558387A (en) PROCESS FOR PRODUCING PRACTICAL PURE, WATER-SOLUBLE KONJAC MANNAN.
DK132447B (en) Method for producing calf diarrhea virus vaccine.
DK120159B (en) Analogous process for the preparation of p-alkyloxy, p-alkenyloxy, p-alkynyloxy or p-cycloalkenyloxyphenylacetic acids or salts thereof.
DK114644B (en) Process for the preparation of antigenic, non-toxic influenza virus subunit vaccines.
DK121052B (en) Process for the preparation of steroid-17α, 21-orthocarbonates.
DK133979B (en) Analogous process for the preparation of 5-methyl-10- (beta-alkylaminethyl) -dibenzo (b, f) -azepines or salts thereof.
DK123710B (en) Analogous process for the preparation of N, N-dimethyl-3- (3-hydroxyphenyl) -propionamidines or acrylamidines or acid addition salts thereof.
DK129590B (en) Process for the preparation of live vaccine against infectious bursitis in chickens.
DK117559B (en) Process for the preparation of cooling-acting 2-alkyl-3,3-diphenylacrylic acids or their salts.
DK119939B (en) Process for the preparation of tetanus vaccine.
DK126223B (en) Method for producing turf.
DK116736B (en) Process for the preparation of 5-chloro-2,3-pyridinediol.
DK113866B (en) Process for the preparation of somatic antigen vaccines.
DK128789B (en) Method for producing a severely attenuated live rubella virus vaccine.
DK130307B (en) Process for the preparation of 3-oxo-13β-alkyl-17β-hydroxy-17α-ethynylgona-4,9-dienes.
DK122824B (en) Method for attenuating viruses.
DK119826B (en) Process for the preparation of α-6-deoxytetracycline, α-6-deoxy-5-oxytetracycline or acid addition salts thereof.
DK135853B (en) Method for producing a killed vaccine against infectious coryza.

Legal Events

Date Code Title Description
PBP Patent lapsed